Idiopathic Pulmonary Fibrosis and Cyclosporine*: A Lesson From Single-Lung Transplantation

    loading  Checking for direct PDF access through Ovid


Idiopathic pulmonary fibrosis (IPF) has a poor prognosis and therapeutic options are limited with a 5-year survival of less than 50%. This report includes a case of histologically confirmed IPF in a patient whose native lung showed objective improvement as measured by high-resolution CT while he was receiving cyclosporine-based immunosuppressive therapy after single-lung transplantation.

(CHEST 1998; 114:1478-1481)

Related Topics

    loading  Loading Related Articles